1. Introduction {#sec0001}
===============

Generally, a successful drug delivery system needs to build a biocompatible carrier which has a high drug loading capacity and allows controlled release of the cargo when it reaches its destination [@bib0001]. Recently, mesoporous silica nanoparticles with a systematic tailorable pore architecture and the high surface area have attracted attention because of their potential use as vehicles for drug delivery [@bib0002], [@bib0003]. Methods that can affect the porosity, pore morphology, pore size distribution and the morphology of the materials are of particular interest. Factors, such as the hydrolysis of silicate, the shape of the surfactant micelles, inorganic salts, organic swelling agents and co solvents, can affect the morphology of the products [@bib0004]. In the preparation of mesoporous silicates, the addition of organic swelling agents, for example, 1,3,5-trimethylbenzene (TMB), n-hexane and n-nonane, which may be soluble in the hydrophobic cores of the surfactant micelles, can lead to a larger micelle size and a greater pore diameter [@bib0005]. Apart from a pore-expanding effect, the swelling agents can also produce some changes in the morphology of the materials. For example, when the concentration of TMB is low, a hexagonally packed pore structure is achieved, and increasing the TMB/P123 ratio will produce a new mesocellular foam phase. When 1,3,5-triisopropylbenzene is used as a swelling agent, a hexagonal structure can be obtained at a low TIPB/P123 ratio while a vesicle-like silica produces a high TIPB/P123 ratio [@bib0006]. To our knowledge, the mesostructure assembly is also greatly affected by the formation of O/W emulsions, while the combination of an emulsion and a templating agent in the synthesis of mesoporous silica materials has received little attention.

Since the inorganic carriers have many favorable properties, such as a high surface area, large pore volume and tunable pore size, much research has focused on applications involving drug delivery systems [@bib0007], [@bib0008]. In addition to immediate-release, there also many research studies on controlled drug release [@bib0009]. Sun et al. have explored a novel spherical nanosilica matrix (SNM) together with chitosan encapsulated SNM to investigate the feasibility of using chitosan to regulate the drug release rate from porous silica and obtain an oral sustained drug delivery system. The dispersing effect of SNM and the swelling of chitosan were the two main factors contributing to the sustained drug release behavior. From the research described above, it appears that the dissolution rate is considered as the most important factor determining the bioavailability of orally administered poorly water-soluble drugs.

Highly basic novel mesoporous materials have been successfully produced by dispersing MgO on SBA-15 using three different methods, impregnation, microwave irradiation and a combination of these, via the magnesium acetate path [@bib0010]. Also, Wang et al. [@bib0011] have reported that MgO particles did not destroy the SBA-15 mesoporous structure after their incorporation. A few years later, there was an investigation of silica particles which were functionalized using their basic properties for the controlled release of ibuprofen with acidic groups [@bib0012]. Shen et al. [@bib0013] synthesized submicron MgO-modified SBA-15 silica. Compared with SBA-15, the amount of ibuprofen adsorbed on the MgO-modified silica was increased and the release rate from the mesoporous matrix was retarded.

In this paper, the swelling agent n-decane in an O/W emulsion-assisted self-assembly process was used to obtain novel 3-dimensional silica cocoons with a larger micelle size and, consequently, leading to a greater pore diameter. In addition, the cocoons doped with magnesia using an *in situ* one-spot method by adding magnesium nitrate to the process for synthesizing MSNCs, and then the basic mesoporous materials from the strongly acidic system were obtained. Matrices with different Mg/Si ratios were obtained for the efficient encapsulation of the acidic drug IMC and they exhibited different adsorption and release behaviors. To our knowledge, little research has been published on the investigation of the detailed adsorption characteristics of the drug adsorption kinetics and isotherm models of IMC adsorption onto such mesoporous silicon cocoons. We also used pseudo-first-order and pseudo-second-order kinetics to obtain a better understanding of the controlling reaction pathways, whether chemisorption or physisorption, and the mechanisms of surface *versus* intraparticle diffusion involved in the adsorption reactions. Kinetic data were used to predict the rate at which the drug IMC was adsorpted onto MgO-MSNCs and the equilibrium adsorption isotherms were used to quantify the adsorptive capacity of the adsorbent.

2. Materials and methods {#sec0002}
========================

2.1. Materials {#sec0003}
--------------

EO~20~PO~70~EO~20~ (Pluronic P123) was obtained from Sigma-Aldrich (St. Louis, MO, USA). Ammonium fluoride was purchased from Aladdin (Shanghai, China). Tetraethyl orthosilicate (TEOS), hydrochloric acid and magnesium nitrate hexahydrate were purchased from Yu Wang Reagent Company (Shandong, China) while n-decane was kindly donated by Fushun Beiyuan Fine Chemical Company Ltd. (Fushun, China). Indomethacin (purity \> 99.0%) was kindly supplied by Shijiazhuang Pharmaceutical Group (Huasheng Pharm. Co., Ltd.). All other chemicals were of reagent grade and used as purchased without further purification.

2.2. Preparation of MSNCs and MgO-MSNCs {#sec0004}
---------------------------------------

The preparation procedure of MSNCs was as follows: 2.5 g P123 was added to 80 ml of 1.0 M HCl solution at room temperature. After a clear solution was obtained, 7.4 g n-decane was added, and the mixture was gently stirred overnight to solubilize the cores of the P123 micelles. After stopping stirring, the P123-decane-water mixture was stand for 8 h to obtain a water-rich layer and a decane-rich layer and then 0.03 g NH~4~F was added to the remaining water-rich layer. This water-rich layer was stirred at 40 °C for 15 min, followed by the dropwise addition of tetraethyl orthosilicate. The mixture was then stirred at 40 °C for 24 h and hydrothermally treated in an autoclave at 100 °C for 48 h. The product was recovered by evaporation, and re-dispersed in distilled water. After stirring at 40 °C for 2 h, filtered and washed with deionized water, then dried at 60 °C overnight. Finally, the white powder obtained was calcined at 550 °C for 6 h to remove the template agent P123.

The MgO-MSNCs were prepared by the same method, except for the addition of a different molar ratio of Mg(NO~3~)~2~•6H~2~O to the water-rich layer and stirred for 0.5 h before 0.03 g NH~4~F was added.

2.3. Sample characterization {#sec0005}
----------------------------

TEM (TECNAI G220, FEI, USA) observations provide information about the mesoporous structure of carriers. The pore volumes and size distributions were obtained using a surface area analyzer (SA3100, Beckman Coulter, USA). The method of Brunauer--Emmett--Teller (BET) was used for determining the surface area of samples. And the method of Barrett--Joyner--Halenda (BJH) was used to determine the pore size distribution. FT-IR (Bruker IFS 55, Switzerland) was used to obtain information about the characteristics of the organic groups on the surface of the samples over a spectroscopic range of 500--4000 cm^−1^. DSC experiments were conducted using a differential scanning calorimeter (DSC 60, Shimadzu Co., Japan). Sample was heated at 10 °C/min under N~2~ flow of 40 ml/min in an aluminum pan. XRD was performed on a diffractometer (PANALY IICALB.V, PW3040/60) with Cu-Kα radiation (λ = 1.5405 Å). Powder samples were scanned over the 2θ angle range from 5° to 60° with a scan rate of 5.0°/min. The basicity of the samples was measured as follow: the sample was shaken in 0.02 M hydrochloric acid solution (5 ml), and the remaining acid was then titrated by standard base (0.02 M aqueous NaOH), then the basicity of the samples was obtained by calculation.

2.4. Adsorption experiments {#sec0006}
---------------------------

Different Mg/Si ratios affected the adsorption kinetics of IMC by MgO-MSCNs, and 10 mg samples of MgO-MSCNs (Mg/Si = 0, 0.4, 0.6, 0.8, 1.0) were added to EP tubes containing 2 ml IMC methanol solution. A sealing film was capped to the EP tubes to avoid methanol volatilization during the equilibration process. Experiments were carried out in a temperature controlled table concentrator. Samples were collected at 0, 10, 20, 30, 45, 60, 120, 180 and 240 min for IMC analysis. Adsorption isotherms were obtained by varying the initial IMC concentration from 0.5 to 5 mg/ml in 2 ml EP tubes with 10 mg carriers. The samples were collected at 0 and 48 h to quantify the initial and final IMC concentrations.

The IMC uptake *q* (mg IMC per g MgO-MSCNs) was determined by mass balance, as follows [@bib0014]:$$q_{t} = \left( {C_{0} - C_{t}} \right) \times V/m$$Where *C*~0~ and *C~t~* are IMC concentrations (mg/l) at time 0 and *t*, respectively, *V* is the volume of the solution (ml), and *m* is the mass of MgO-MSCNs (mg).

2.5. Drug loading procedure {#sec0007}
---------------------------

IMC was incorporated into the pores of MgO-MSNCs samples by an adsorption equilibrium method. In detail, the carriers and IMC/methanol (10 mg/ml) were mixed (the mass ratio of IMC to carrier was 1/3, w/w). Then, the mixture was allowed to reach adsorption equilibrium under gently stirring for 24 h at room temperature in a closed container. Finally, the mixture was centrifuged at 10 000 rpm to obtain a powder precipitate which was washed with methanol to remove residual drug on the surface of the carrier. The product was then dried at 40 °C until the organic solvent was removed. The loaded samples were referred as IMC-MSCNs and IMC-MgO-MSCNs.

2.6. In vitro study of the dissolution rate {#sec0008}
-------------------------------------------

Dissolution experiments were carried out in phosphate buffer (pH 6.2), using a USP II paddle method (75 rpm, 37 °C and 900 ml dissolution medium) with a dissolution instrument (KC-8D, Tianjin Guoming Medical Equipment Co. Ltd.). At first, IMC-loaded samples (equivalent to 20 mg IMC) were added to the dissolution medium, and then 5 ml samples of the release medium were collected and passed through a 0.22 µm membrane filter at regular intervals. Finally, the concentration of the released IMC was determined at 318 nm by UV--vis spectrophotometry (UV-2000, Unico, USA).

2.7. In vitro cytotoxicity studies {#sec0009}
----------------------------------

Caco-2 cells were cultured using Dulbecco\'s Modified Eagle\'s Medium (DMEM) supplemented with 10% FBS, 1% non-essential amino acids, penicillin and streptomycin. The culture was maintained at 37 °C at an atmosphere of 5% CO~2~ and 95% relative humidity. To evaluate the *in vitro* cytotoxicity of the MSNCs and MgO-MSNCs nanoparticles, Caco-2 cells were seeded onto 96-well plate at a density of 2 × 10^4^/well at 37 °C for 24 h. Subsequently, the cells treated with various concentrations of MSNCs and MgO-MSNCs carriers (20, 50, 100, 200, 500 µg/ml) for another 24 h. The cell viability was evaluated by using MTT 3-\[4, 5-dimethylthiazol-2-yl\]−2, 5-diphenyltetrazolium bromide) assay. Then, 20 µl MTT (5 mg/ml) solution was added into each well and further incubation for 4 h at 37 °C. Finally, the mixture was taken out and 150 µl DMSO was added into the wells to dissolve the formazan crystals produced by the living cells. The absorption of each well was measured at a wavelength of 570 nm using a microplate reader (SpectraMax M3, Molecular Devices, USA).

3. Results and discussion {#sec0010}
=========================

3.1. Sample morphology characterization {#sec0011}
---------------------------------------

During the preparation process of MSNCs, triblock copolymer P123 was used as a template due to its ability to self-organize into micelles. The addition of the organic swelling agent n-decane, which was soluble in the hydrophobic cores of the surfactant micelles, will produce a larger micelle size and, consequently, leading to a greater pore diameter [@bib0005]. Compared with the traditional mesoporous silica material SBA-15, which was known as a rod-shaped morphology with uniform pore size, the addition of n-decane made the structures of MSNCs become 3-dimensional cocoon-like pouches instead of 2-dimensional nano-chunks as shown in [Fig. 1](#fig0001){ref-type="fig"}A and B. Therefore, n-decane might play two roles in the synthesis process. Initially, it acted as a swelling agent to produce P123 micelles with a large diameter. More importantly, n-decane allowed the formation of the O/W emulsion, in which the P123 micelles aggregated to form a layer by layer structure. When the silica source (TEOS) was added to the water-rich-layer obtained, a hydrolysis reaction occurred, giving a mesostructured nanocomposite. After calcination, the triblock copolymers were removed, and the final product was obtained.Fig. 1TEM images of (A, B) MSCNs, (C) 0.4MgO-MSCNs, (D) 0.6MgO-MSCNs, (E) 0.8MgO-MSCNs, and (F) 1.0MgO-MSCNs.Fig 1

The MgO-MSNCs were prepared *in situ* by a one-spot method, in which Mg(NO~3~)~2~•6H~2~O was added to the water-rich layer and stirred for 0.5 h before 0.03 g NH~4~F was added. This resulted in basic mesoporous material being obtained from the strongly acidic system. The inner structures of MSNCs and MgO-MSNCs were characterized by TEM and the results are shown in [Fig. 1](#fig0001){ref-type="fig"}. It was found that the materials are 3-dimensional cocoon-like pouches. The wall of these cocoons is curved and the ordered channels are also curved. These perspective images were due to superposition of the nanosized cocoon-like units. The TEM results indicated that the addition of the precursor salt Mg(NO~3~)~2~•6H~2~O in synthetic process did not markedly change the mesoscopic order of the MSNCs, and the smooth MgO layers were formed on the surface of MSNCs.

Another interesting phenomenon is that magnesium oxide was obtained in a strongly acidic solution (pH \< 1) without interaction, since the magnesium oxide was alkaline. But how the magnesium ions enter the curved and ordered channels of the as-made sample, this may be attributed to the mobility of P123 in the channels of the material. Since the surfactant can be easily extracted by water, it also enables Mg^2+^ cations to migrate and combine with the PEO head of P123 in the inner pores. At the same time, Mg^2+^ cation also has a chance to connect with surface silanol groups. According to the preparation procedure, when the sample was removed from the evaporation step without further drying and calcination, and re-dispersed in the distilled water, the pH value was less than 1, indicating that the large amount of HCl remained in the sample, no MgO may exist in such acidic condition. Then the mixture was continued to stir at 40 °C for 2 h, filtrated, washed with water, dried at 60 °C and calcined at 550 °C. Based on these observations, incorporation of magnesium in MSNCs did not occur in the initial hydrothermal step, but probably in the evaporation step. The magnesium species survived in the strong acid solution (pH \< 1), of course they were not basic or soluble but probably anchored with surface silanol groups. Once the Si--O--Mg monolayer is formed, they would be converted to an MgO layer in the calcination process, changing both the surface area and pore volume of MSCNs [@bib0015]. The 0.4MgO-MSNCs, 0.6MgO-MSNCs, 0.8MgO-MSNCs and 1.0MgO-MSNCs samples possesses a basicity of 10.69, 17.86, 21.79 and 31.94 mmol OH^−^/g in titration as shown in Fig. S1, respectively. The size distribution and polydispersity index (PDI) were measured to identify the uniformity of nanoparticles as shown in [Fig. 2](#fig0002){ref-type="fig"}. The diameters of MgO-MSCNs with different Mg/Si ratios were about 1000--1700 nm with the PDI less than 0.3, indicating that the carriers had the relatively uniform particle sizes.Fig. 2The diameter and PDI of MgO-MSCNs with different Mg/Si ratios.Fig 2

The structures of the products were also investigated by the Brunauer--Emmett--Teller (BET) nitrogen adsorption isotherm, which is shown in [Fig. 3](#fig0003){ref-type="fig"}A. From the figure, the specific surface area of the sample ranges from 478.99 m^2^/g to 524.32 m^2^/g, and ordered mesoporous materials with a narrow pore size distribution from 9.79 nm to 16.01 nm are suggested by the inset of [Fig. 3](#fig0003){ref-type="fig"}A. Compared with the conventional SBA-15, the larger pore size is probably due to the presence of n-decane in the P123 micelles [@bib0016].Fig. 3(A) Nitrogen adsorption desorption isotherms and pore size distributions (the inset) of MgO-MSCNs with different molar ratios; (B) Specific surface area and pore volume changes at different molar ratios for MgO-MSNCs.Fig 3

The pore diameter, surface area and total pore volume of different samples are shown in [Table 1](#tbl0001){ref-type="table"} and [Fig. 3](#fig0003){ref-type="fig"}B. The surface area, total pore volume and pore diameter were all increased with an increase in the content of magnesium nitrate. This can be explained by the Hofmeister theory, in which Na^+^, Cl^−^ and CH~3~COO^−^ are generally salting-out ions, which can be regarded as water-structure-makers or cosmotropic ions, while Mg^2+^ and NO~3~^−^ are salting-in ions, as we call them, water-structure-breakers or chaotropic ions [@bib0015]. Due to the salting-in nature of Mg^2+^ and NO~3~^−^, the added magnesium nitrate enhances the formation of the polar environment, and hinders the dehydration of PEO blocks, which promotes the formation of the hybrid interface between the silica and PEO segments, followed by an increase in the surface area and pore volume of MSNCs. A schematic illustration of the *in-situ* emulsion-assisted process is proposed in [Scheme 1](#fig0011){ref-type="fig"}.Table 1Pore diameter, surface area and total pore volume of different MgO-MSCNs samples.Table 1Table 1Different ratios*D~p~* (nm)*S*~BET~ (m^2^/g)*V~t~* (cm^3^/g)Mg/Si = 09.79478.991.26Mg/Si = 0.410.82500.961.34Mg/Si = 0.612.34513.811.45Mg/Si = 0.813.21522.641.72Mg/Si = 116.01524.321.77Scheme 1Schematic illustration of the in-situ emulsion-assisted process of MgO-MSNCs.Fig sch1

3.2. Adsorption kinetics {#sec0012}
------------------------

The adsorption of drug molecules onto porous matrix materials is determined by the pore size distribution and surface properties. The pore size of supporting carrier determines the number of drug molecules that can be adsorbed into its channels. In other words, compared with classic SBA-15 materials, more drug molecules may be adsorbed into such cocoon-like silica materials due to the larger pore size. Owing to the alkaline surface of MgO-MSCNs, it was also very useful for the acidic drug loading. The adsorption kinetics of the products was used to investigate the saturated adsorption capacity of MgO-MSCNs.

The molar ratio of Mg/Si is an important factor in the adsorption process. The effect of the molar ratio on the adsorption of IMC by MgO-MSCNs was studied from 0 to 1 at *C*~0~ = 2 mg/ml and an MgO-MSCNs mass of 10 mg. As shown in [Fig. 4](#fig0004){ref-type="fig"}, an increase in the molar ratio resulted in an increased IMC adsorption rate and equilibrium sorption capacity, with the equilibrium IMC adsorption increasing from 28.34 mg/g at Mg/Si = 0 to 67.94 mg/g at Mg/Si = 1, while the time required to reach sorption equilibrium was 240 min. This may be attributed to that the basicity of MgO-MSCNs was stronger at a higher molar ratio of Mg/Si, which resulted in stronger combining force interaction between MgO-MSCNs and the carbonyl group of model drugs IMC.Fig. 4Effect of molar ratio of Mg/Si on the adsorption kinetics of IMC by MgO-MSCNs.Fig 4

Parameters from two kinetic models, pseudo-first-order [@bib0017] and pseudo-second-order [@bib0018], were fitted to the experimental data to evaluate the adsorption kinetics of IMC uptake by MgO-MSCNs.

The pseudo-first-order equation describes adsorption in solid--liquid systems based on the sorption capacity of solids [@bib0017]. The linear form of the pseudo-first order model can be expressed as:$$\text{log}\left( {q_{e} - q_{t}} \right){= \text{log}}q_{e} - k_{1}t{/2}{.303}$$Where *q~e~* and *q~t~* (mg/g) are the adsorption capacities at equilibrium and at time *t*, respectively.

The constants, *k*~1~ and *q~e~*, in the experiment were calculated using the slope and intercept of plots of log(*q~e~* − *q~t~*) *versus t* ([Table 2](#tbl0002){ref-type="table"}, [Fig. 5](#fig0005){ref-type="fig"}A). The fit lines at each Mg/Si ratio yielded relatively low *R*~1~^2^ values and the experimental observations suggests that application of the equation is inappropriate as the experimental observations are nonlinear when plotted in this manner. In addition, the agreement between the experimentally observed equilibrium adsorption and that derived using [Eq. (2)](#eqn0002){ref-type="disp-formula"} is poor. This suggests that the adsorption of IMC on MgO-MSCNs did not follow pseudo-first-order kinetics.Table 2Adsorption kinetic model rate constants for IMC adsorption on MgO-MSCNs.Table Table 2Sample*q~e,~*~exp~ (mg/g)First-orderSecond-order*k~1~* (min)*q~e,~*~cal~ (mg/g)*R*~1~^2^*k~2~* *×* *10^−3^* (g/mg/min)*q~e,~*~cal~ (mg/g)*R*~2~^2^MSNCs28.340.00677.990.836337.4427.320.99920.4MgO-MSNCs36.710.00908.870.74316.1434.010.99650.6MgO-MSNCs40.650.011310.450.73147.7135.710.99930.8MgO-MSNCs50.840.012411.730.79378.2249.020.99921.0MgO-MSNCs67.940.019343.170.97428.1571.430.9784Fig. 5(A) Pseudo first-order kinetic and (B) pseudo second-order kinetic model fit for IMC sorption onto MgO-MSCNs at various molar ratios (*n* = 3).Fig 5

The pseudo-second-order rate expression [@bib0018] can be linearly expressed as:$$t/q_{t} = {1/}k_{2}{q_{e}}^{2} + t/q_{e}$$Where *k*~2~ is the rate constant for pseudo-second-order adsorption (g/mg/h) and *k*~2~*q~e~*^2^ or *h* (mg/g/h) is the initial adsorption rate.

The experimental values of the solid phase concentration of adsorbate at equilibrium (*q~e~*~,exp~) and the calculated value of the solid phase concentration of adsorbate at equilibrium (*q~e~*~,calc~) for the pseudo-second-order models are also shown in [Table 2](#tbl0002){ref-type="table"} and [Fig. 5](#fig0005){ref-type="fig"}B. Shows that the fitted equilibrium adsorption capacities derived from [Eq. (3)](#eqn0003){ref-type="disp-formula"} are similar at each molar ratio and in close agreement with those observed experimentally, and also, the calculated correlation coefficients (*R*~2~^2^) are also closer to unity of pseudo-second-order kinetics. Therefore, the IMC adsorption by MgO-MSCNs can be more appropriately described by the pseudo-second-order kinetic model and IMC is adsorbed onto MgO-MSCNs via a chemical interaction.

3.3. Adsorption isotherms {#sec0013}
-------------------------

Various adsorption isotherm equations were used to describe the equilibrium nature of adsorption. The Freundlich isotherm is suitable for highly heterogeneous surfaces, while the Langmuir equation [@bib0019] is valid for homogeneous surfaces. Regarding the Temkin isotherm, this takes into accounting the interactions between the adsorbing material and the adsorbate. The isotherm assumes that the heat of adsorption of the molecules decreases linearly with coverage due to their interactions and the adsorption is characterized by a uniform distribution of binding energies [@bib0020].

In this experiment, the adsorption of IMC by MgO-MSCNs was modeled using the Freundlich ([Fig. 6](#fig0006){ref-type="fig"}A), Langmuir ([Fig. 6](#fig0006){ref-type="fig"}B), and Temkin isotherms ([Fig. 6](#fig0006){ref-type="fig"}C). The isotherm constants and the correlation coefficient (*R*^2^) with the experimental data are listed in [Table 3](#tbl0003){ref-type="table"}.Fig. 6(A) Freundlich, (B) Langmuir and (C) Temkin isotherms for IMC adsorption on MgO-MSCNs (*n* = 3).Fig 6Table 3Langmuir, Freundlich, and Temkin isotherm model parameters and correlation coefficients for adsorption of IMC on MgO-MSCNs.Table Table 3IsothermSampleParameters*k~F~nR^2^*FreundlichMSNCs0.0741.240.98950.4MgO-MSNCs0.1351.350.98800.6MgO-MSNCs0.1181.290.95680.8MgO-MSNCs0.1481.090.97471.0MgO-MSNCs0.1961.340.9926  LangmuirSample*q~m~* (mg/g)*k*~L~ × 10^5^ (l/mg)*R^2^*MSNCs177.588.830.98480.4MgO-MSNCs233.2910.420.97980.6MgO-MSNCs237.1111.430.95950.8MgO-MSNCs238.2612.860.96121.0MgO-MSNCs275.4413.010.9868  TemkinSample*k~T~* × 10^3^*bR^2^*MSNCs2.6724.510.93010.4MgO-MSNCs2.9225.100.93070.6MgO-MSNCs2.7929.420.90910.8MgO-MSNCs2.8631.100.88021.0MgO-MSNCs3.7632.200.8970

The Freundlich isotherm is suitable for both monolayer and multilayer adsorption, and it is based on the assumption that the adsorbate is adsorbed on the heterogeneous surface of an adsorbent [@bib0021]. The linear form is expressed as:$$\text{log}\, q_{e}{= \text{log}}\, K_{F} + \text{log}\, C_{e}/n$$Where *K~F~* and *n* are Freundlich isotherm constants related to the adsorption capacity and adsorption intensity, respectively and *C~e~* is the equilibrium concentration (mg/l).

The Freundlich isotherm constants *K~F~* and 1/*n* represent the adsorption capacity and adsorption intensity, respectively. Since the *n* values are greater than one, this indicates that the affinity between the adsorbate and adsorbent is high. In other words, IMC is well adsorbed by MgO-MSNCs. The high correlation coefficients (*R*^2^) indicate that the interaction between the two materials is one of chemisorption.

Since the Freundlich isotherm does not predict the saturated adsorption capacity of the adsorbent surface by the adsorbate. So, the maximum adsorption capacity of adsorbent (*q~m~*) is calculated by the Langmuir isotherm equation.

The Langmuir isotherm assumes that only monolayer adsorption can occur on the surface of the adsorption sites. Once a site is filled, no other sorption can take place at that position. When the surface eventually reaches saturation, the maximum adsorption will be obtained. The Langmuir isotherm model is described as:$$C_{e}/q_{e}{= 1/}K_{L}q_{m} + C_{e}/q_{m}$$Where *K~L~* is the Langmuir constant related to the energy of adsorption and *q~m~* is the maximum adsorption capacity (mg/g) [@bib0021].

The parameters of IMC adsorption on MgO-MSCNs were in good agreement with the observed behavior. In the equation, *K~L~* indicates the affinity of IMC for the adsorbents, and the maximum adsorption capacity of IMC ranged from 177.58 mg/g to 275.44 mg/g with an increasing Mg/Si molar ratio.

The Temkin isotherm model assumes that the adsorption energy decreases linearly with the surface coverage. The linear form of the Temkin isotherm is:$$q_{e}{= \text{RT}}\ln K_{T}/b{+ \text{RT}}\ln C_{e}/b$$Where *b* is the Temkin constant related to the heat of sorption (J/mol) and *K~T~* is the Temkin isotherm constant (l/g) [@bib0022].

The Temkin isotherm model is also used to confirm whether the interaction between the adsorbate and the adsorbent is one of chemisorption [@bib0023]. From [Table 3](#tbl0003){ref-type="table"}, the correlation coefficients (\>0.90) demonstrated that the adsorption of IMC on MgO-MSCNs fitted quite well with the Temkin isotherm equation. This further supports the finding that the adsorption of IMC onto MgO-MSCNs particles was dominated by a chemisorption process.

3.4. Drug loading and characterization {#sec0014}
--------------------------------------

In the drug loading process, IMC was incorporated into MgO-MSCNs samples by the adsorption equilibrium method. Methanol was selected as the solvent because of the good solubility of IMC in methanol. The drug loading amount was determined by UV spectrometry, and the results are listed in [Table 4](#tbl0004){ref-type="table"}. The drug loading amount of IMC in five different carriers increased with an increasing of Mg/Si molar ratio, which was in agreement with the results of adsorption kinetics experiments. The surface areas and pore size of the obtained carriers were significantly reduced after drug loading. Because the basicity of the carrier enhanced with the increase of MgO doping ratio in composites, and the binding force with the acidic drug was also increased. The larger space of the carrier surface and the channel occupied by the drug IMC, the smaller surface area of the carrier after drug loading.Table 4Property characterization for drug carriers after drug loading.Table 4Table 4Sample*D~p~* (nm)*S*~BET~ (m^2^/g)*V~t~* (cm^3^/g)Loading content (%)MSNCs\<2102.900.7312.95 ± 1.230.4MgO-MSNCs\<287.630.5714.88 ± 0.970.6MgO-MSNCs\<235.800.3015.75 ± 1.010.8MgO-MSNCs\<218.100.1818.95 ± 0.591.0MgO-MSNCs\<25.740.0423.45 ± 0.77

The morphology of the drug-loaded samples was studied by TEM as shown in Fig. S2. Compared with unloaded MgO-MSCNs samples, most of the pore channels were not clear, indicating that a large number of the pore channels had been filled with IMC. In addition, the diameter and PDI of IMC-1.0MgO-MSCNs was 1127 nm with a PDI of 0.306, which was similar to that of 1.0MgO-MSCNs.

The physical state of IMC in MgO-MSNCs was characterized by XRD and DSC. Powder samples were scanned over the 2θ angle range from 10° to 60°, and XRD result is shown in [Fig. 7](#fig0007){ref-type="fig"}A. The raw IMC showed intense and characteristic crystalline diffraction peaks at 2θ = 11.4°, 17.5°, 19.5°, 21.6° and 25.2°. However, no distinctive crystalline peaks of the drug were observed after the drug loaded into the mesoporous MgO-MSNCs composite, indicating that the drug loaded in the carrier was in an amorphous state. DSC measurements were used to further verify the physical state of IMC. As shown in [Fig. 7](#fig0007){ref-type="fig"}B, IMC raw drug has a sharp melting point, however, there was no endothermic peak in the range of 50--400 °C in IMC loaded samples. The results showed that the drug can be completely loaded into the inner channel of the carrier, and the drug was in an amorphous state, which is consistent with the results of XRD.Fig. 7(A) XRD pattern and (B) DSC profiles of IMC, IMC-MSNCs, IMC-0.4MgO-MSNCs, IMC-0.6MgO-MSNCs, IMC-0.8MgO-MSNCs and IMC-1.0MgO-MSNCs.Fig 7

FTIR spectrum can also provide the evidence of anion complexion with cation in the sample of MSNCs and MgO-MSNCs as shown in [Fig. 8](#fig0008){ref-type="fig"}A. The peaks at 1090.8 and 804.0 cm^−1^ of unmodified mesoporous MSNCs were because of the asymmetric and symmetric stretching of Si--O--Si lattice vibrations, respectively. The peaks at 1634.6 and 960.6 cm^−1^ were attributed to Si--OH. After the MSNCs were assembled by MgO, the characteristic peak of Si--OH at 1634.6 cm^−1^ became stronger with increasing MgO simultaneously. It could be explained as follows, with the increasing of MgO content, the number of water molecules interacting with the Si--O--Si of MSNCs was also increased in order to form the surface hydroxyls. When the MgO ratio rises to 1.0, the peak began to decrease. This phenomenon may be explained by the surface hydroxyls beginning to release H^+^, which leading to decreased amounts of the surface hydroxyls.Fig. 8FTIR spectra of (A) MSNCs and MgO-MSNCs, and (B) IMC encapsulated in MSNCs and MgO-MSNCs.Fig 8

To get a better understanding of the intercalation mode between the IMC drugs and the prepared silica matrix, the FTIR spectrum was also used to describe the possible intermolecular interactions, as depicted in [Fig. 8](#fig0008){ref-type="fig"}B. The characteristic peaks of pure IMC were 1717.6 and 1691.4 cm^−1^, which were corresponding to the carbonyl group of the acid and amide, respectively. In contrast, when the IMC-loaded silica were formulated, the originally carbonyl stretching peaks became weaker and broader, and shifted to lower wave numbers of 1705 and 1678 cm^−1^, respectively. This phenomenon indicated that the acid and amide functional groups of IMC were reacted with the hydroxyl of the silica surface. Some researchers have been published on the interactions between acid drug molecules and unmodified or MgO modified silica matrices, wherein the hydroxyl group on the surface of silica tends to interact with the carbonyl group of the drug [@bib0012]. The FTIR results confirmed that IMC have been successfully loaded into the obtained mesoporous silica materials.

3.5. In vitro release profiles {#sec0015}
------------------------------

*In vitro* release tests were carried out to study the application of MgO-MSCNs as a drug carrier and to investigate the effect of different Mg/Si ratios of samples on the dissolution behavior of IMC. The release of IMC from MgO-MSCNs mainly involved two stages: burst release and slow release. The reason for the initial burst release was probably due to the fact that the drug is present in the outer pores of mesoporous materials. As shown in [Fig. 9](#fig0009){ref-type="fig"}(A) and (B), the release rate of IMC from pure MSNCs was much faster than that from raw IMC. Since IMC is a BCS class II drug, the dissolution rate of IMC within 1 h was about 65% because of its poor dissolution. So, the most likely reason for the improved dissolution may be the spatial confinement of the MSNCs pores, which reduced the degree of IMC crystallization and maintained the drug in a non-crystalline state, which effectively increased the dissolution rate. Because of the addition of swelling agents, MSCNs have relatively larger pores (9.79 nm), and the spacious pore channels means they encounter less diffusion resistance and escape more easily into the dissolution medium. The whole release process of the drug molecules involves the drug dissolving in the dissolution medium and escaping from the pore channels. Therefore, larger pores allow the dissolution medium to penetrate more easily into the carriers pore channels, and the drug molecules would have more chance of being released from the carriers. So, it could be predicted that MSNCs could significantly increase the release rate of poorly water-soluble drugs owing to their large pores and open pore structure.Fig. 9Dissolution profiles of MgO-MSNCs with different molar ratios and raw IMC (A) 48 h and (B) 6 h.Fig 9

In [Fig. 9](#fig0009){ref-type="fig"}A and B, the release rates of IMC from MgO-MSCNs samples were slower with an increase in the Mg/Si ratio. The dissolution rate of IMC from the Mg/Si = 1 sample within 1 h was only about 29%, while the Mg/Si = 0 sample had a release rate of IMC of 92%. In the first 6 h, 95% of the IMC was released from the Mg/Si = 0 sample, and the cumulative release of IMC from Mg/Si = 1 sample was 57%. After 6 h, the release rate slowed down. The maximum amount of IMC released is 85% and 99% within 48 h, respectively. The different dissolution rates can be attributed to the formation of stronger bonds between the acidic IMC drugs and basic samples compared with those between the drugs and MgO-MSCNs. With the increasing Mg/Si ratio, the amount of the surface hydroxyl was higher, IMC with the carbonyl group of the acid and amide was apt to interact with the surface of the carriers and, so the interaction between them is greater, which results in a slower release rate. Since all the five carriers possess a similar morphology, the pore size may also influence the release rate. However, to our surprise, the larger pore size of Mg/Si = 1 did not markedly influence the rate of drug release. In our drug delivery system, the combination of an acidic drug and alkaline carriers plays the most important role.

3.6. In vitro cell cytotoxicity evaluation {#sec0016}
------------------------------------------

The results of MTT assays in [Fig. 10](#fig0010){ref-type="fig"} indicated that both MSCNs and MgO-MSCNs exhibited negligible cytotoxicity on Caco-2 cells at tested concentrations. Even at the highest concentration of 500 µg/ml, cell viability was higher than 85%. The negligible cell cytotoxicity of MgO-MSCNs against Caco-2 cells might due to the relatively large particle size which was hardly to be uptake by the cells. These results indicated that MSCNs and MgO-MSCNs could be used as the safe carriers for oral drug delivery.Fig. 10Effect of MSNCs and MgO-MSNCs on cell viability of Caco-2 cells by MTT assay.Fig 10

4. Conclusion {#sec0017}
=============

In summary, the novel ordered mesoporous MgO-modified mesoporous silica cocoons (MgO-MSNCs) with different Mg/Si molar ratio were prepared to encapsulate the acidic drugs. The adsorption was found to be strongly dependent on the Mg/Si molar ratio. The IMC adsorption rate and the maximum adsorption capacity with the increase of Mg/Si molar ratio. And the adsorption kinetics could be accurately described by the pseudo-second-order kinetic model. The Freundlich isotherm produced a good fit, indicating that the coverage of the MgO-MSNCs surface with IMC was heterogeneous. The maximum adsorption capacity of adsorbent is calculated by the Langmuir isotherm equation. The experimental data also fitted the Temkin equation well, which further supports the hypothesis that the IMC adsorption on MgO-MSNCs was dominated by a chemisorption process. Since MgO-MSNCs samples have a stronger affinity for drug molecules compared with pure MSNCs, MgO-MSNCs have the advantage of adjusting the drug release rate of IMC. We also believe that our research on MgO-MSNCs carriers highlights the potential therapeutic benefits associated with the safe and effective management of the acidic drug adsorption and *in vitro* release.
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